Real-world Effectiveness and Safety of Treatment With DAAs in Patients With CHC(Chronic Hepatitis C) - Trial NCT03887637
Access comprehensive clinical trial information for NCT03887637 through Pure Global AI's free database. This phase not specified trial is sponsored by Third Affiliated Hospital, Sun Yat-Sen University and is currently status unknown. The study focuses on Chronic Hepatitis C. Target enrollment is 180 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Third Affiliated Hospital, Sun Yat-Sen University
Timeline & Enrollment
N/A
Mar 30, 2019
Sep 30, 2019
Primary Outcome
SVR(Sustained Virologic Response)12
Summary
This is a multi-center, open-label clinical study. This study was aimed to assess the
 real-world effectiveness and safety of treatment with listed DAAs in patients with CHC and
 cirrhosis in Southern area of China.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT03887637
Non-Device Trial